• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by Axcelis Technologies Inc.

    2/2/26 7:02:19 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology
    Get the next $ACLS alert in real time by email
    425 1 tm264507d2_425.htm 425

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): January 22, 2026

     

    Axcelis Technologies, Inc.

    (Exact Name of Registrant as Specified in Charter)

     

    Delaware   000-30941   34-1818596
    (State or Other Jurisdiction   (Commission   (IRS Employer
    of Incorporation)   File Number)   Identification No.)

     

    108 Cherry Hill Drive
    Beverly, Massachusetts
    01915

    (Address of Principal Executive Offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (978) 787-4000

     

    N/A

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    xWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      
    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
      
    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
      
    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange
    on which registered
    Common Stock, $.001 par value   ACLS   Nasdaq Global Select Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 8.01 Other Events.

     

    As previously announced, on September 30, 2025, Axcelis Technologies, Inc., a Delaware corporation (“Axcelis”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among Axcelis, Victory Merger Sub, Inc., Delaware corporation and a direct wholly owned subsidiary of Axcelis (“Merger Sub”) and Veeco Instruments Inc., a Delaware corporation (“Veeco”), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into Veeco, with Veeco surviving such merger as a wholly owned subsidiary of Axcelis (the “Merger”).

     

    On January 22, 2026, the United Kingdom Investment Security Unit issued a no further action letter with respect to the Merger.

     

    Additionally, Axcelis and Veeco, in accordance with the Merger Agreement, determined that in light of the facts and circumstances, filings are not required under the Investment Screening Law of Sweden. On January 27, 2027, Axcelis and Veeco waived (a) the condition to closing solely with respect to approval under any Investment Screening Law of Sweden having been obtained (or applicable waiting periods in connection therewith having expired) and (b) the corresponding efforts covenants solely with respect to such approval.

     

    Axcelis and Veeco continue to cooperate with respect to the final pending regulatory approval from the State Administration for Market Regulation of the People’s Republic of China.

     

    The completion of the Merger remains subject to other customary closing conditions, including the approval of the issuance of Axcelis common stock pursuant to the Merger Agreement by Axcelis stockholders and the adoption of the Merger Agreement by Veeco stockholders. As previously announced, each of Axcelis and Veeco have special meetings of their respective stockholders scheduled for February 6, 2026. Institutional Shareholder Services Inc. and Glass, Lewis & Co. have both recommended that Veeco stockholders vote FOR approval of the Merger and that Axcelis stockholders vote FOR approval of the issuance of Axcelis shares in connection with the Merger.

     

    Axcelis and Veeco continue to expect that the Merger will be completed in the second half of 2026.

     

    Additional Information About the Potential Transaction and Where to Find It

     

    In connection with the proposed transaction between Axcelis and Veeco pursuant to the Merger Agreement, on December 8, 2025, Axcelis filed with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4, as amended on December 29, 2025 (the “Registration Statement”). The Registration Statement on Form S-4 was declared effective by the SEC on December 31, 2025. Each of Axcelis and Veeco filed a definitive joint proxy statement/prospectus (the “Joint Proxy Statement/Prospectus”) with the SEC on December 31, 2025 and commenced mailing to their respective stockholders on or about December 31, 2025. Each of Axcelis and Veeco may also file with or furnish to the SEC other relevant documents regarding the proposed Merger. This current report on Form 8-K is not a substitute for the Joint Proxy Statement/Prospectus or any other document that Axcelis or Veeco has filed or may file with or furnish to the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE OR WILL BE FILED WITH OR FURNISHED TO THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND RELATED MATTERS. Investors and security holders will be able to obtain free copies of the Joint Proxy Statement/Prospectus and other documents containing important information about Axcelis, Veeco and the proposed transaction, once such documents are filed with or furnished to the SEC through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with or furnished to the SEC by Axcelis will be available free of charge on Axcelis’ website at investor.axcelis.com or by contacting Axcelis’ Investor Relations department by email at [email protected]. Copies of the documents filed with or furnished to the SEC by Veeco will be available free of charge on Veeco’s website at ir.veeco.com or by contacting Veeco’s Investor Relations department by email at [email protected].

     

     

     

     

    Participants in the Solicitation

     

    Axcelis, Veeco and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed Merger. Information about the directors and executive officers of Axcelis, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Axcelis’ proxy statement for its 2025 annual meeting of stockholders, which was filed with or furnished to the SEC on March 31, 2025. Information about the directors and executive officers of Veeco, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Veeco’s proxy statement for its 2025 annual meeting of stockholders, which was filed with the SEC on March 20, 2025. Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the Joint Proxy Statement/Prospectus and other relevant materials to be filed with or furnished to the SEC regarding the proposed transaction. You may obtain free copies of these documents using the sources indicated above.

     

    No Offer or Solicitation

     

    This document is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

     

    Forward-Looking Statements

     

    Certain statements included in this document, and any related oral statements, that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Statements in this document other than historical facts, such as statements pertaining to: (i) future industry demand for semiconductors and wafer fabrication equipment; (ii) future development of regulatory landscape; (iii) Axcelis’ or Veeco’s market position for the future; (iv) forecasts of financial measures for future periods; (v) long-term financial targets and underlying assumptions; (vi) the future investment plan for research and development, technology and infrastructure; (vii) future shareholder returns; and (viii) potential synergies or other benefits of a potential transaction between Axcelis and Veeco, are forward-looking statements.

     

    Any statements that involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events, or performance (often but not always using phrases such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “budget,” “scheduled,” “forecasts,” “estimates,” “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could,” “would,” “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information.

     

     

     

     

    These forward-looking statements are based on current information and assumptions and involve a number of risks and uncertainties, including relating to obtaining applicable regulatory and stockholder approvals, satisfying other closing conditions to the proposed transaction, the expected tax treatment of the proposed transaction, the expected timing of the proposed transaction and the integration of the businesses and the expected benefits, cost savings, accretion, synergies and growth to result therefrom. These risks include, among other things: failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise; failure to satisfy other closing conditions to the proposed transaction or to complete the proposed transaction on anticipated terms and timing; negative effects of the announcement of the proposed transaction; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the proposed transaction will harm business plans and operations; risks relating to unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities; restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the proposed transaction; the potential impact of the announcement or consummation of the proposed transaction on Axcelis’, Veeco’s or the combined company’s relationships with suppliers, customers, employees and regulators; and demand for the combined company’s products. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: economic, political and social conditions in the countries in which Axcelis and Veeco, their respective customers and suppliers operate; disruption to Axcelis’ and Veeco’s respective manufacturing facilities or other operations, or the operations of Axcelis’ and Veeco’s respective customers and suppliers, due to natural catastrophic events, health epidemics or terrorism; ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns; Axcelis’, Veeco’s and the combined company’s ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry; Axcelis’, Veeco’s and the combined company’s ability to maintain their respective technology advantage and protect their respective proprietary rights; Axcelis’, Veeco’s and the combined company’s ability to compete with new products introduced by their respective competitors; Axcelis’, Veeco’s and the combined company’s ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China.

     

    For other factors that may cause actual results to differ materially from those projected and anticipated in forward-looking statements in this Current Report on Form 8-K, please refer to Axcelis’ most recent Annual Report on Form 10-K and Veeco’s most recent Annual Report on Form 10-K, and other subsequent filings with the SEC made by Axcelis and/or Veeco. Unless required by law, we assume no obligation to, and do not currently intend to, update these forward-looking statements.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      AXCELIS TECHNOLOGIES, INC.
       
      By: Eileen J. Evans
    Date: February 2, 2026   Eileen J. Evans
        Executive Vice President HR/Legal and General Counsel

     

     

     

    Get the next $ACLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLS

    DatePrice TargetRatingAnalyst
    10/13/2025$90.00Neutral → Underperform
    BofA Securities
    10/2/2025$105.00Hold → Buy
    The Benchmark Company
    4/21/2025$50.00Buy → Neutral
    B. Riley Securities
    2/12/2025Outperform → Mkt Perform
    William Blair
    11/8/2024Buy → Hold
    The Benchmark Company
    5/3/2024$130.00Hold → Buy
    Craig Hallum
    12/15/2023Buy → Neutral
    BofA Securities
    9/15/2023$225.00Buy
    BofA Securities
    More analyst ratings

    $ACLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Axcelis Announces Participation in SEMICON Korea 2026

    Highlighting New Technologies That Advance Intelligent Semiconductor Manufacturing Solutions BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform of ion implanters at SEMICON Korea 2026. The event will take place February 11–13 at the COEX Center in Seoul, South Korea. SEMICON Korea will feature key technology developments shaping the next generation of semiconductor manufacturing, including AI driven process control, advanced packaging methodologies, and sustainable, high efficiency fab operations.

    2/4/26 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Unveils Purion H6: Next-Generation High Current Ion Implanter for Advanced Semiconductor Manufacturing

    BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today introduced the Purion H6™ high current ion implanter—engineered to meet the demands of next-generation semiconductor devices with unmatched purity, precision and productivity. The Purion H6 builds on the success of the well-established Purion H product line, integrating new technologies to support today's most advanced device manufacturing. This next generation system combines a high throughput be

    2/4/26 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Timing and Availability of Fourth Quarter and Full Year 2025 Results and Conference Call

    BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register

    1/26/26 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    SEC Filings

    View All

    SEC Form 425 filed by Axcelis Technologies Inc.

    425 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/2/26 7:02:19 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Technologies Inc. filed SEC Form 8-K: Other Events

    8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)

    2/2/26 7:00:43 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Technologies Inc. filed SEC Form 8-K: Other Events

    8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)

    1/28/26 5:18:14 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Low Russell bought $49,452 worth of shares (440 units at $112.39), increasing direct ownership by 0.77% to 57,754 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    3/11/24 4:15:28 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Coogan James Gordon bought $11,223 worth of shares (100 units at $112.23), increasing direct ownership by 2% to 5,991 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    2/29/24 4:15:26 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Lawson Douglas A. bought $55,520 worth of shares (500 units at $111.04), increasing direct ownership by 3% to 19,648 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    2/26/24 8:15:07 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Global Operations Mahoney Robert John was granted 1,734 shares, increasing direct ownership by 13% to 15,206 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    1/16/26 5:05:05 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    New insider Mahoney Robert John claimed ownership of 13,472 shares (SEC Form 3)

    3 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    12/22/25 5:09:43 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    EVP, General Counsel and Sec'y Evans Eileen covered exercise/tax liability with 1,378 shares, decreasing direct ownership by 5% to 24,406 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    12/18/25 5:05:05 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Axcelis Tech downgraded by BofA Securities with a new price target

    BofA Securities downgraded Axcelis Tech from Neutral to Underperform and set a new price target of $90.00

    10/13/25 8:47:48 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Tech upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00

    10/2/25 8:33:47 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Tech downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00

    4/21/25 8:31:51 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Leadership Updates

    Live Leadership Updates

    View All

    Axcelis Technologies Appoints David Ryzhik Senior Vice President of Investor Relations and Corporate Strategy

    The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.

    6/27/24 4:01:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure at Leading Power Device Manufacturers in Japan

    BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,

    4/2/24 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

    SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin

    7/15/21 4:30:00 PM ET
    $CLPT
    $ACLS
    Medical/Dental Instruments
    Health Care
    Industrial Machinery/Components
    Technology

    $ACLS
    Financials

    Live finance-specific insights

    View All

    Axcelis Announces Timing and Availability of Fourth Quarter and Full Year 2025 Results and Conference Call

    BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register

    1/26/26 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Financial Results for Third Quarter 2025

    Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased

    11/4/25 7:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Timing and Availability of Third Quarter 2025 Results and Conference Call

    BEVERLY, Mass., Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.c

    10/22/25 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Axcelis Technologies Inc.

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    11/8/24 2:17:22 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/13/24 4:58:56 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/9/24 4:18:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology